{"id":"NCT02450526","sponsor":"Ipsen","briefTitle":"Dysport in the Treatment of Glabellar Lines in Chinese Subjects","officialTitle":"A Phase III, Randomised, Double Blind and Open Label Phase, Multicentre, Active and Placebo Controlled Study to Investigate the Efficacy and Safety of Dysport Including a Comparison to Botox in the Treatment of Moderate to Severe Glabellar Lines, and to Assess the Long Term Efficacy and Safety of Dysport Following Repeated Treatments in This Indication","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2015-04","primaryCompletion":"2016-07","completion":"2017-09-06","firstPosted":"2015-05-21","resultsPosted":"2019-06-06","lastUpdate":"2019-08-06"},"enrollment":520,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Glabellar Lines"],"interventions":[{"type":"BIOLOGICAL","name":"Botulinum toxin type A","otherNames":["AbobotulinumtoxinA (Dysport速)"]},{"type":"BIOLOGICAL","name":"Botulinum toxin type A","otherNames":["OnabotulinumtoxinA (Botox速)"]},{"type":"DRUG","name":"Placebo","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"AbobotulinumtoxinA","type":"EXPERIMENTAL"},{"label":"OnabotulinumtoxinA","type":"ACTIVE_COMPARATOR"},{"label":"AbobotulinumtoxinA Placebo","type":"PLACEBO_COMPARATOR"},{"label":"OnabotulinumtoxinA Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The objective of this study is to demonstrate the efficacy of Dysport for the improvement in appearance of moderate to severe glabellar lines and to assess the short term and long term safety of Dysport, used for the improvement in appearance of moderate to severe glabellar lines in Chinese subjects.","primaryOutcome":{"measure":"Superiority Analysis of The Percentage of Responders Measured by the Investigator's Live Assessment (ILA) at Maximum Frown at Cycle 1, Day 29 (DB Period).","timeFrame":"At Cycle 1, Day 29.","effectByArm":[{"arm":"Dysport速 50 U - DB Period","deltaMin":95.2,"sd":null},{"arm":"Dysport速 Placebo - DB Period","deltaMin":0.9,"sd":null},{"arm":"Botox 20 U - DB Period","deltaMin":94,"sd":null},{"arm":"Botox Placebo - DB Period","deltaMin":4.3,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.0001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":7,"exclusionCount":19},"locations":{"siteCount":10,"countries":["China"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":5,"n":326},"commonTop":["Upper respiratory tract infection","Viral upper respiratory tract infection","Eyelid ptosis","Headache","Hyperlipidaemia"]}}